Ask AI
ProCE Banner Activity

New Hope in GI Cancer Care: A Candid Conversation with Dr Yelena Janjigian

Video

In this episode of Candid Conversations, Dr John Marshall sits down with GI cancer expert Dr Yelena Janjigian, to discuss the success of the Matterhorn study and progress being made to improve outcomes for patients with stomach and esophageal cancers.

Since the recording of this interview, the US Food and Drug Administration approved durvalumab with FLOT chemotherapy as neoadjuvant and adjuvant treatment, followed by single agent durvalumab, for adults with resectable gastric or gastroesophageal junction adenocarcinoma.

Released: December 18, 2025